Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
67,294,590
-
Share change
-
+60,674,422
-
Total reported value
-
$130,551,000
-
Price per share
-
$1.94
-
Number of holders
-
49
-
Value change
-
+$117,945,812
-
Number of buys
-
33
-
Number of sells
-
7
Institutional Holders of VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) as of Q4 2020
As of 31 Dec 2020,
VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,294,590 shares.
The largest 10 holders included
VR Adviser, LLC, NEA Management Company, LLC, Acuta Capital Partners, LLC, ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, Ikarian Capital, LLC, VANGUARD GROUP INC, COMMODORE CAPITAL LP, SPHERA FUNDS MANAGEMENT LTD., and Ghost Tree Capital, LLC.
This page lists
49
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.